As part of one of the nation’s leading academic medical centers, UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center offers a broad spectrum of clinical trials aimed at improving the outcomes of patients with leukemia. Talk with your doctor if you’re interested in joining a clinical trial.
Some of our current clinical trials include:
- A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients with AML or MDS
- A Safety and Tolerability Study of Crenolanib in Combination with Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients with FLT3 Mutations
- Combination Chemotherapy in Treating Young Patients with Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
- Collecting and Storing Samples of Bone Marrow and Blood From Patients with Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Request an Appointment
To schedule a visit with a leukemia specialist at UT Southwestern's facilities in Dallas or to learn more about our services, request an appointment or call 214-645-8300.